pentamidine has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, T; Cox, D; Motoyama, Y; Seki, J; Yoshida, K | 1 |
1 other study(ies) available for pentamidine and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist.
Topics: Amino Acid Sequence; Antiprotozoal Agents; Cell Line; Cells, Cultured; Endothelium, Vascular; Epitopes; Fibrinogen; Humans; Hydrogen-Ion Concentration; Molecular Sequence Data; Oligopeptides; Pentamidine; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex | 1996 |